← Back to SMMT

Summit Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 23/07/2026Mar 2026Filed 23/07/2026Sep 2025Filed 20/10/2025Jun 2025Filed 23/07/2026Mar 2025Filed 23/07/2026Sep 2024Filed 20/10/2025Jun 2024Filed 20/10/2025Mar 2024Filed 20/10/2025
$0
−$216−$189−$232−$566−$63−$56−$60−$43
−$0.28−$0.24−$0.31−$0.76−$0.09−$0.08−$0.09−$0.06
778775743743738727708702

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.